Majorczyk, E.; Mazurek-Mochol, M.; Pawlik, A.; Kuśnierczyk, P.
Clinical Factors and the Outcome of Treatment with Methotrexate in Rheumatoid Arthritis: Role of Rheumatoid Factor, Erosive Disease and High Level of Erythrocyte Sedimentation Rate. J. Clin. Med. 2022, 11, 6078.
https://doi.org/10.3390/jcm11206078
AMA Style
Majorczyk E, Mazurek-Mochol M, Pawlik A, Kuśnierczyk P.
Clinical Factors and the Outcome of Treatment with Methotrexate in Rheumatoid Arthritis: Role of Rheumatoid Factor, Erosive Disease and High Level of Erythrocyte Sedimentation Rate. Journal of Clinical Medicine. 2022; 11(20):6078.
https://doi.org/10.3390/jcm11206078
Chicago/Turabian Style
Majorczyk, Edyta, Małgorzata Mazurek-Mochol, Andrzej Pawlik, and Piotr Kuśnierczyk.
2022. "Clinical Factors and the Outcome of Treatment with Methotrexate in Rheumatoid Arthritis: Role of Rheumatoid Factor, Erosive Disease and High Level of Erythrocyte Sedimentation Rate" Journal of Clinical Medicine 11, no. 20: 6078.
https://doi.org/10.3390/jcm11206078
APA Style
Majorczyk, E., Mazurek-Mochol, M., Pawlik, A., & Kuśnierczyk, P.
(2022). Clinical Factors and the Outcome of Treatment with Methotrexate in Rheumatoid Arthritis: Role of Rheumatoid Factor, Erosive Disease and High Level of Erythrocyte Sedimentation Rate. Journal of Clinical Medicine, 11(20), 6078.
https://doi.org/10.3390/jcm11206078